Victory Capital Management Inc Atara Biotherapeutics, Inc. Transaction History

Victory Capital Management Inc

$98.4 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$1.41 - $2.31 $664 - $1,088	471 Added 4.67%	10,555 $15,000
Q2 2023 Jul 27, 2023	SELL	$1.5 - $3.04 $351 - $711	-234 Reduced 2.27%	10,084 $16,000
Q1 2023 May 02, 2023	BUY	$2.8 - $5.46 $103 - $202	37 Added 0.36%	10,318 $29,000
Q4 2022 Feb 09, 2023	SELL	$2.85 - $5.18 $11 - $20	-4 Reduced 0.04%	10,281 $33,000
Q3 2022 Nov 02, 2022	SELL	$2.85 - $8.73 $3,226 - $9,882	-1,132 Reduced 9.92%	10,285 $39,000

Q2 2022 Aug 01, 2022	BUY	$4.69 - $9.84 $1,927 - $4,044	411 Added 3.73%	11,417 $89,000
Q1 2022 May 04, 2022	SELL	$8.44 - $16.89 $2,650 - $5,303	-314 Reduced 2.77%	11,006 $70,000
Q4 2021 Feb 07, 2022	BUY	$14.7 - $19.89 $3,807 - $5,151	259 Added 2.34%	11,320 $178,000
Q3 2021 Nov 02, 2021	SELL	$11.99 - $17.9 $15,107 - $22,554	-1,260 Reduced 10.23%	11,061 $198,000
Q2 2021 Aug 03, 2021	SELL	$12.89 - $16.58 $4,034 - $5,189	-313 Reduced 2.48%	12,321 $192,000
Q1 2021 May 04, 2021	SELL	$14.0 - $20.72 $6,538 - $9,676	-467 Reduced 3.56%	12,634 $181,000
Q4 2020 Feb 01, 2021	BUY	$12.67 - $26.23 $25,301 - $52,381	1,997 Added 17.98%	13,101 $257,000
Q3 2020 Nov 09, 2020	SELL	$11.92 - $15.87 $2,503 - $3,332	-210 Reduced 1.86%	11,104 $144,000
Q2 2020 Aug 07, 2020	BUY	$7.53 - $14.93 $14,269 - $28,292	1,895 Added 20.12%	11,314 $165,000
Q1 2020 May 04, 2020	SELL	$5.69 - $17.78 $5,490 - $17,157	-965 Reduced 9.29%	9,419 $80,000
Q4 2019 Feb 06, 2020	BUY	$10.89 - $16.79 $15,910 - $24,530	1,461 Added 16.37%	10,384 $171,000
Q4 2019 Feb 04, 2020	BUY	$10.89 - $16.79 $11,020 - $16,991	1,012 Added 12.79%	8,923 $118,000
Q3 2019 Nov 12, 2019	BUY	$12.03 - $19.94 $95,169 - $157,745	7,911 New	7,911 $112,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

Eco R1 Capital, LLC San Francisco, CA

10.2M
Shares

$78.4 Million
0.2% of portfolio
Redmile Group, LLC San Francisco, CA

9.26M
Shares

$71.4 Million
0.25% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$52.7 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

6.58M
Shares

$50.7 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

6.51M
Shares

$50.2 Million
0.0% of portfolio

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account